X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7498) 7498
Magazine Article (37) 37
Publication (36) 36
Newsletter (32) 32
Book Chapter (31) 31
Newspaper Article (31) 31
Dissertation (6) 6
Streaming Video (5) 5
Conference Proceeding (4) 4
Book / eBook (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dabigatran (5878) 5878
humans (4694) 4694
warfarin (3494) 3494
rivaroxaban (3059) 3059
anticoagulants (2659) 2659
atrial fibrillation (2502) 2502
apixaban (1959) 1959
anticoagulants - therapeutic use (1940) 1940
male (1940) 1940
stroke (1827) 1827
female (1798) 1798
aged (1661) 1661
administration, oral (1646) 1646
dabigatran etexilate (1590) 1590
atrial fibrillation - drug therapy (1505) 1505
cardiac & cardiovascular systems (1441) 1441
anticoagulants - adverse effects (1433) 1433
anticoagulants - administration & dosage (1411) 1411
stroke - prevention & control (1216) 1216
prevention (1194) 1194
atrial-fibrillation (1175) 1175
peripheral vascular disease (1169) 1169
hematology (1126) 1126
middle aged (1113) 1113
venous thromboembolism (1052) 1052
beta-alanine - analogs & derivatives (1047) 1047
hemorrhage - chemically induced (1040) 1040
atrial fibrillation - complications (1024) 1024
risk factors (1022) 1022
thromboembolism (949) 949
treatment outcome (943) 943
management (917) 917
medicine, general & internal (895) 895
safety (878) 878
benzimidazoles - therapeutic use (857) 857
aged, 80 and over (854) 854
pharmacology & pharmacy (854) 854
risk (849) 849
anticoagulation (833) 833
stroke prevention (790) 790
warfarin - therapeutic use (785) 785
therapy (752) 752
oral anticoagulants (722) 722
bleeding (703) 703
abridged index medicus (689) 689
thrombin (679) 679
stroke - etiology (651) 651
benzimidazoles - adverse effects (632) 632
cardiac arrhythmia (625) 625
dabigatran - therapeutic use (596) 596
direct thrombin inhibitor (593) 593
hemorrhage (583) 583
analysis (567) 567
beta-alanine - therapeutic use (564) 564
pyrazoles - therapeutic use (564) 564
pyridones - therapeutic use (564) 564
care and treatment (556) 556
drug therapy (545) 545
antithrombins - therapeutic use (539) 539
edoxaban (535) 535
thrombosis (530) 530
benzimidazoles - administration & dosage (524) 524
efficacy (522) 522
antithrombins - adverse effects (518) 518
warfarin - adverse effects (518) 518
medicine & public health (516) 516
dabigatran - adverse effects (511) 511
patients (494) 494
blood coagulation - drug effects (476) 476
direct oral anticoagulants (471) 471
pharmacokinetics (466) 466
vitamin k - antagonists & inhibitors (463) 463
beta-alanine - adverse effects (462) 462
retrospective studies (450) 450
surgery (444) 444
pyridines - therapeutic use (439) 439
mortality (436) 436
dabigatran - administration & dosage (432) 432
dosage and administration (430) 430
antithrombotic therapy (429) 429
cardiology (428) 428
adult (423) 423
metaanalysis (418) 418
warfarin - administration & dosage (412) 412
thromboembolism - prevention & control (402) 402
enoxaparin (401) 401
reversal (399) 399
risk assessment (395) 395
double-blind (392) 392
thiophenes - therapeutic use (390) 390
morpholines - therapeutic use (389) 389
antithrombins - administration & dosage (385) 385
aspirin (379) 379
fibrillation (379) 379
venous thromboembolism - prevention & control (376) 376
anticoagulants - pharmacology (363) 363
pyrazoles - administration & dosage (360) 360
pyridones - administration & dosage (360) 360
factor xa inhibitors (358) 358
beta-alanine - administration & dosage (351) 351
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6921) 6921
German (307) 307
French (191) 191
Spanish (190) 190
Russian (104) 104
Japanese (70) 70
Czech (44) 44
Portuguese (44) 44
Italian (24) 24
Polish (24) 24
Hungarian (23) 23
Danish (12) 12
Swedish (12) 12
Turkish (12) 12
Chinese (6) 6
Dutch (6) 6
Norwegian (6) 6
Slovenian (6) 6
Finnish (4) 4
Korean (4) 4
Slovak (2) 2
Arabic (1) 1
Croatian (1) 1
Estonian (1) 1
Persian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 5, pp. 431 - 441
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 17, pp. 1627 - 1636
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 07/2016, Volume 134, Issue 3, pp. 248 - 261
Vitamin K antagonists are commonly used by clinicians to provide anticoagulation to patients who have or are at risk of having thrombotic events. In addition... 
anticoagulants | atrial fibrillation | venous thromboembolism | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ACTIVATED FACTOR-VII | ATRIAL-FIBRILLATION | IN-VITRO | THROMBIN GENERATION | DABIGATRAN ETEXILATE | PROTHROMBIN COMPLEX CONCENTRATE | SYMPTOMATIC VENOUS THROMBOEMBOLISM | PRACTICAL MANAGEMENT | PERIPHERAL VASCULAR DISEASE | STAGE RENAL-DISEASE | FACTOR XA INHIBITOR | Recombinant Proteins - therapeutic use | Plasma | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Thiazoles - therapeutic use | Factor VIIa - therapeutic use | Arginine - analogs & derivatives | Dabigatran - therapeutic use | Thiazoles - adverse effects | Pyridines - adverse effects | Rivaroxaban - adverse effects | Factor Xa - therapeutic use | Rivaroxaban - therapeutic use | Factor Xa - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Piperazines - therapeutic use | Dabigatran - antagonists & inhibitors | Piperazines - adverse effects | Factor Xa Inhibitors - therapeutic use | Hemorrhage - drug therapy | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Blood Coagulation Factors - therapeutic use | Arginine - adverse effects | Pyridones - therapeutic use | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Arginine - therapeutic use | Pyridones - adverse effects
Journal Article
Journal Article
The American journal of medicine, ISSN 0002-9343, 2015, Volume 128, Issue 12, pp. 1300 - 1305.e2
Journal Article